BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1662882)

  • 21. A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis.
    Cox CE; Marbury TC; Pittman WG; Brown GL; Auerbach SM; Fox BC; Yang JY
    Clin Ther; 2002 Feb; 24(2):223-36. PubMed ID: 11911553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of temafloxacin in the community setting: an overview.
    Ball P
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():121-30. PubMed ID: 1664825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole.
    Guibert J; Capron MH
    J Int Med Res; 1992 Nov; 20(6):467-74. PubMed ID: 1337525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group.
    Henry D; Ellison W; Sullivan J; Mansfield DL; Magner DJ; Dorr MB; Talbot GH
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2262-6. PubMed ID: 9736546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
    Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of sparfloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection.
    Naber KG; di Silverio F; Geddes A; Guibert J
    J Antimicrob Chemother; 1996 May; 37 Suppl A():135-44. PubMed ID: 8737133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections.
    Hoepelman IM; Havinga WH; Benne RA; Zwinkels M; de Wit MA; de Hond HA; Boon TA; Visser MR; van Asbeck FW; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):343-7. PubMed ID: 8394815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens.
    Richard GA; Mathew CP; Kirstein JM; Orchard D; Yang JY
    Urology; 2002 Mar; 59(3):334-9. PubMed ID: 11880065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
    Symonds WT; Nix DE
    Clin Pharm; 1992 Sep; 11(9):753-66. PubMed ID: 1325892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temafloxacin vs ciprofloxacin for UTI.
    Ganiats TG; Norcross WA
    J Fam Pract; 1992 Jul; 35(1):14, 16, 18. PubMed ID: 1319461
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of complicated urinary tract infections with lomefloxacin compared with that with trimethoprim-sulfamethoxazole.
    Nicolle LE; Louie TJ; Dubois J; Martel A; Harding GK; Sinave CP
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1368-73. PubMed ID: 8092839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis.
    Naber KG;
    Int J Antimicrob Agents; 2002 Jul; 20(1):18-27. PubMed ID: 12127707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin].
    Guibert J; Herman H; Capron MH
    Contracept Fertil Sex; 1997 Jan; 25(1):79-84. PubMed ID: 9064058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind randomized study of oral temafloxacin and cefadroxil in patients with mild to moderately severe bacterial skin infections.
    Neldner KH
    Am J Med; 1991 Dec; 91(6A):111S-114S. PubMed ID: 1662879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The U.S. clinical experience with lomefloxacin, a new once-daily fluoroquinolone.
    Rizk E
    Am J Med; 1992 Apr; 92(4A):130S-135S. PubMed ID: 1316063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expanding role of fluoroquinolones.
    Schaeffer AJ
    Am J Med; 2002 Jul; 113 Suppl 1A():45S-54S. PubMed ID: 12113871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study.
    Pisani E; Bartoletti R; Trinchieri A; Rizzo M
    J Chemother; 1996 Jun; 8(3):210-3. PubMed ID: 8808718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study of sparfloxacin, a new quinolone derivative, on urinary tract infection].
    Suzuki K; Horiba M; Naide Y; Shinoda M; Hibi H; Okishio N; Yanagioka M; Nagakubo I
    Hinyokika Kiyo; 1991 Dec; 37(12):1749-57. PubMed ID: 1664649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia.
    Carbon C; LĂ©ophonte P; Petitpretz P; Chauvin JP; Hazebroucq J
    Antimicrob Agents Chemother; 1992 Apr; 36(4):833-9. PubMed ID: 1323954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temafloxacin: a safe antibiotic for the elderly, patients with comorbidities, and other special populations.
    Pernet AG
    Am J Med; 1991 Dec; 91(6A):162S-165S. PubMed ID: 1662888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.